Accelerating CHO Media Development: From Screening To AI Design

Lessons In Building Connected Lab Operations Across Development And GMP

Evaluating Modular CAR T Manufacturing Workflows

Scaling Cell And Gene Therapy Manufacturing

IND In As Little As 6 Months: Now Beyond mAbs - Accelerating Bispecifics, Fc-Fusions And High-Concentration Biologics To The Clinic

How Sodium Hydroxide CIP Affects Column Performance And Resin Lifetime

Annex 1 In Practice: Turning CCS Into Cleanroom Design

De-Risking The Path To GMP Manufacturing At Another Organization

Challenges And Opportunities For MSC Expansion Workflows

Improving Scale-Up Starts With Expression Strategy

Improving Clinical Translation For ADCs And Immuno-Oncology With Human-Relevant Tumor Models

A Smarter Microbial Approach To Therapeutic Peptide Manufacturing

Challenges To Developing High Concentration Formulation For Multi-Specific Antibodies

mAb Aggregate Control On-Demand Webinar

How Perfusion In Seed Train Bioreactors Can Simplify Upstream Processes

Introducing New Technology To A Multi-Specific Antibody Line

Improved Clearance Of Host Cell Proteins After Virus Inactivation

Driving Optimization Through Connected Laboratory Environments

Legal & Compliance Impact On Speed In The Antibody Market

Optimizing Antibody Variant Capture: Strategies To Combat Aggregation, Impurities, And Low Yields

Build Process Robustness Through Deeper Process Understanding

Intensification Of Upstream Operations With Dynamic Perfusion

Enhancing mRNA-LNP Downstream Processing Via Single-Pass TFF

A Practical Roadmap For Column Sizing, System Selection, And GxP Readiness

Role Of Membrane Chemistry And Filter Format In TFF

Recombinant Protein Process Development And Scale-Up

Accelerating CHO Media Development: From Screening To AI Design

Evaluating Modular CAR T Manufacturing Workflows

Driving Productivity Across The Antibody Manufacturing Workflow

De-Risking Cell Culture Media Scale-Up For Late-Stage Manufacturing

Driving Measurable Productivity Gains In CHO Cell Culture

The Future Of Cell Culture Media Development

From Data To Decisions: AI And Multi-Omics For Cell Culture Development

How Modular Workflows Are Redefining CAR T Manufacturing

Reducing Particulate-Related Batch Risk In Bioprocessing

How Intensified Upstream Processing Improves Scale-Up And Tech Transfer

Generate Stable High-Producing Clones In 14 Weeks

Using Residual DNA Quantification Data To De-Risk mAb Development

Enabling Assurance Of Supply Through Evolving Bioprocessing Needs

Why Is The Bioreactor Square? The Geometry Behind Exceptional Mixing

Accelerating The Development Of New Protein Therapeutics

HyPerforma 5:1 Single-Use Bioreactor (S.U.B.) Setup And Installation Part 3

Perfusion: Hardware Needs

Nunc Cell Factory Incubator

Cell Culture Media Manufacturing, Grand Island, NY

Demo Of At-Line Cell Culture Media Analyzer

Cell Insights By Umetrics® Studio

Discover The Benchtop DynaDrive Single-Use Bioreactor

Inside Bioprocessing: Multi-Omics

How To Use 5 And 10L BPCs Of The CTS Optmizer Family Of Serum Free Media

Intensify Your Seed Train With The BioContinuum™ Seed Train Platform

Supporting Cells To Overcome Shear Forces

Prepare your CHO Cells For Higher Productivity By Optimizing Perfused Seed Train

SAFC Cell Culture Solutions

Optimize Cell Culture Media

How To Fill And Empty Nunc Standard Closed Cell Factory System

How To Use 5 And 10L BPCs Of The CTS Optmizer Family Of Serum Free Media

How To Fill And Empty Nunc Standard Cell Factory System

How To Use Mobius® Single-Use Assembly For High Cell Density Cryopreservation

Mycap® Bottle Closures – Aseptic Fluid Transfer Systems For Bottles

Multi-Specific Antibody Development: What Challenges The Need For Speed?

MilliporeSigma Large Scale Capabilities Tour

The CHO Toolkit: Flexible Solutions For Complex Molecules

STUDIUS™ & ICON™: Data-Driven Workflow For The Development Of Modern Cell-Based Therapies

Raman-Based Monitoring Of Multiple Critical Parameters

Overcoming Cloning Inefficiencies To Accelerate New Protein Therapeutics

Solentim VIPS® PRO

A Collaboration With Zurich University Of Applied Sciences

Is The Sensitivity Of Optical Biosensors Important?

SAFC Cell Culture Solutions

Cytovance Customer Testimonial: Thermo Scientific Single-Use Technologies

The STUDIUS™ Powered Ecosystem

What Researchers Should Look For When Choosing A CLD Partner

Optimize Cell Culture Media

CTS DynaCellect Magnetic Separation System Cell Isolation

High-Viability Cell Processing, Simplified

Scalable Single-Use Centrifugation Systems

A Solution To Automate Concentration, Washing, And Medium Exchange

CTS DynaCellect Magnetic Separation System Uninstalling Bead Removal Kit

A Closed And Automated Solution To Streamline Your Workflow

Asahi Kasei Bioprocess - Made In The USA

Using Algae To Manufacture Oral Biologics With Lumen Bioscience's Craig Behnke, Ph.D.

A Closed And Automated Solution For Cell Therapy Manufacturing

New Demands On Biopharma Harvest And Clarification

Teach Me In 10: Techniques For Harvesting Adherent Cells

Finding Ways To Reduce Process COGs Upstream And Downstream

Enabling Assurance Of Supply Through Evolving Bioprocessing Needs

The CHO Toolkit: Flexible Solutions For Complex Molecules

MilliporeSigma Bio-Expo Live February 2025: Upstream Bioprocessing

Meet The Experts: Part 3 - Chemometrics And Model Building

Meet Your Bioprocess Sidekick For Cell Culture Media Analysis

Methods To Process Intensification, Downstream Challenges In Continuous Manufacturing

Supporting Cells To Overcome Shear Forces

Q&A On Continuous Manufacturing In Biopharma

A New Era Of mAb Manufacturing

Overcoming Cloning Inefficiencies To Accelerate New Protein Therapeutics

A Collaboration With Zurich University Of Applied Sciences

Meet The Experts: Part 4 – Applications And Use Of Raman In Bioprocessing

Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding

Growing And Scaling A Radiopharmaceuticals Company With AdvanCell's Philina Lee, Ph.D.

Finding New Opportunities In Obesity With Moonwalk Bioscience's Alex Aravanis, M.D., Ph.D.

Biotech Finance And Investor Update With Independent Board Director Allan Shaw

Funding A Virtual Biotech Without Institutional Capital With Sarcomatrix's David Craig

Picking Biotech Winners Beyond The Hype Cycle With Andera Partners' Olivier Litzka

Biotech Investing At The Earliest Stages With Santé Ventures' Omar Khalil

Getting To A First Product Approval With Celcuity's Brian Sullivan

Cell Therapy Advances And Biotech Leadership With Nkarta's Paul Hastings

A Rescue Model For Shelved Drug Candidates With Annette Bakker, Ph.D. And Andrew Lo, Ph.D.

Using Genetics To Discover New Treatments With Regeneron Genetics Center's Aris Baras, M.D.

Late-Stage Development And Commercial Planning With CervoMed's Matt Winton, Ph.D.

Cooperating With Suppliers To Produce 3D-Printed Prototypes

Creating Technical Debt When Experimenting With 3D Printed Parts

A Case Study In 3D Printing: Shake Flask Jackets

Closing The Data Package Gap For In-House 3D Printed Parts

3D Printing In Process Development And A False Sense Of Qualification

E&L Testing And 3D Printed Single-Use Parts

Comparing Biosimilars To Drifting Reference Product Data

Levers For Streamlining And Optimizing The Biosimilar Process

The Burden Of Proof Has Shifted To Analytics For Biosimilar Approval

In Biosimilar Analytical Development, Is A CQA Ever Not Critical?

Platforming And The Future Of Standardized Manufacturing Chassis

The Necessity Of Potency Assay Matrices For Complex Proteins

In The U.S., Pharmacy-Level Biosimilar Substitution Remains A High Bar

How To Avoid A Biosimilar Comparative Efficacy Study, If Possible

Closing The Data Package Gap For In-House 3D Printed Parts

Addressing Rapid Biomanufacturing Capacity Needs

A Case Study In 3D Printing: Shake Flask Jackets

E&L Testing And 3D Printed Single-Use Parts

Design And Material Selection When 3D Printing Parts

AES Clean Technology Career Opportunities

The Facility Of The Future

Cell Culture Media Manufacturing, Grand Island, NY

Modular Cleanroom Panel Manufacturing Factory Tour

Cleanroom Design Cost Control

Modular Facilities - The Proven Response For Rapid Biomanufacturing Anywhere

Creating Technical Debt When Experimenting With 3D Printed Parts

Life Changing Products: Modernizing Regulated Product Development And Manufacturing

Building A Defensible Visual Inspection Program With Purpose-Built Software

Inline Buffer Formulation Systems

Large-Scale Lentivirus Manufacturing With A Transfection Complex Stabilizer

Modifying Elution Conditions For Enhanced Impurity Removal

Trusted Performance With A Plus: Seamless Transfer From R&D To Commercial

Optimize Every Step In Your Biopharma Site

Streamline Fluid Disconnections And Reduce Tear-Down Complexity

Advanced Adherent Corning Platforms For Scalable Viral Vaccine Manufacturing

Digital Logbooks Improve Data Integrity And Audit Readiness

From Data Promises To Factory Results: Reality Leadership In Pharma

The Importance Of Having A Strong Reject Characterization Program

Methods To Process Intensification, Downstream Challenges In Continuous Manufacturing

Q&A On Continuous Manufacturing In Biopharma

Applications For PAT And Continuous: Seed Trains & Data Anomalies

Why PAT Is Foundational To Continuous Manufacturing & What Stands In The Way

A CDMO Perspective: Bioprocess Automation And Data Management

Sensors & Data: What Feeds Effective Continuous Manufacturing?

Who's Ready For Continuous Manufacturing?

How Do We Quantify Continuous Manufacturing Benefits?

Maximizing Performance And Quality In Fed-Batch And Perfusion-Based IgG Productions Customer Interview

Can Continuous Biomanufacturing Borrow From Small Molecules?

How Industry Orgs, Associations Are Supporting Continuous Manufacturing

Building LEO Pharma's U.S. Presence with Brian Hilberdink

Adoption And Implementation

Boost Scalability And Efficiency With Automated Filtration

Introducing New Technology To A Multi-Specific Antibody Line

Commercial Readiness with Orca Bio's Dan Kirby

A Robust, Future-Ready Solution That Adapts To Your Needs

Master The 2-Point Calibration Process To Maintain Data Integrity

A Closed And Automated Solution For Cell Therapy Manufacturing

Multichannel Verification System And Assay Optimization Platform

Simplifying Bioprocess Data Collection

The Future Of QC Is Now

A Straightforward Path Toward Regulatory Compliance & Data Integrity With Your Microbial Testing Systems

STUDIUS™ & ICON™: Data-Driven Workflow For The Development Of Modern Cell-Based Therapies

Meet Your Bioprocess Sidekick For Cell Culture Media Analysis

LC/MS Method For Measurement In Human Plasma

Elucidating The Role Of IL-18 In NSCLC Integrated Analysis

Is The Sensitivity Of Optical Biosensors Important?

Testing Liquid Handler Performance With PCRMix

ResDNASEQ Workflow Solution

How J&J Is Tackling Alzheimer's Disease With Fiona Elwood, Ph.D.

Can Gene Therapy Be The Solution For CHF With AskBio's Dr. Lothar Roessig

BoB@JPM: Gene Writing With Tessera's Michael Severino, M.D.

Inside A Dopamine-Restoring Cell Therapy For PD With BlueRock Therapeutics' Dr. Amit Rakhit

Real-Time Monitoring And Automated Sampling For Enhanced Efficiency

The CHO Toolkit: Flexible Solutions For Complex Molecules

ADC Heterogeneity, Site-Specific Conjugation

Engineering Bacterial Vector-Based Immunotherapies With OS Therapies' Paul Romness and Robert Petit, Ph.D.

Challenges In ADC Process Development

It's Time To Intensify

Closing The Data Package Gap For In-House 3D Printed Parts

Challenges To Developing High Concentration Formulation For Multi-Specific Antibodies

A Case Study In 3D Printing: Shake Flask Jackets

E&L Testing And 3D Printed Single-Use Parts

Adoption And Implementation

Design And Material Selection When 3D Printing Parts

Boost Scalability And Efficiency With Automated Filtration

Making The Jump To GMP: Material Decisions For Clinical Manufacturing

Ensuring Successful Technology Transfer In ADC Development

Design And Material Selection When 3D Printing Parts

The Risk And Reality Of 3D Printed Parts In Single-Use Workflows

The Levers And Tradeoffs That Drive Process Productivity

Downstream Decisions To Maximize Viral Vector Yields And Reduce COGs

Closing The Adoption Gap For Advanced Single-Use Materials

Process Control's Increasing Role In Biosimilar Approval

Optimizing Process Development Through Upstream And Downstream Integration

Protecting Bioprocessing Operations And Supply Chains In A Turbulent Economy

How Digital Tools Are Accelerating Biopharma Development

Evolving CMC Strategies To Enable Next-Gen ADCs

Building LEO Pharma's U.S. Presence with Brian Hilberdink

The Journey To Safety Through Viral Clearance

How Will U.S. Tariffs And The BIOSECURE Act Impact Global Biopharma Markets?

Selecting The Right CMO For Your Gene Therapy

Commercial Readiness with Orca Bio's Dan Kirby

Thermo Fisher Scientific Customer Testimonial - Libbs

Protecting Biopharma Manufacturing Supply Chains

MilliporeSigma Capacity Update October 2025: ADC

Thermo Fisher Scientific North America Single-Use Technologies Capacity Expansion

What Researchers Should Look For When Choosing A CLD Partner

Regulatory And Biosafety Testing Expertise

Building Resilience In Biomanufacturing Operations

Flexibility First: A Fill And Finish Collaboration Story

Fill And Finish: Your Final Step Is Our First Priority

Enhancing Aseptic Fill-Finish Processes

BioTitan Retention Device Overview

Maximize Your Drug Product Recovery With A Complete Fill Finish Solution

Maintaining Downstream Quality In Multi-Specific Antibody Manufacturing

Multi-Specific Antibody Development: What Challenges The Need For Speed?

Single-Use Filter Transfer Sets Ready For Final Filling

Mycap® Bottle Closures – Aseptic Fluid Transfer Systems For Bottles

Isolator Fill-Finish Process With Single-Use (SU) Systems

Nanoassemblr Blaze mRNA Vaccine Demo

Nanoassemblr Ignite mRNA Vaccine Demo

Strategies For Viral Inactivation And Filtration In Multispecifics

Mobius® Chrom 20 System, For Purification Of Clinical And Process Scale Biologics

Optimized Purity Of A Monoclonal Antibody, Carsten Voß Video

Navigating The Diverse Antibody Pipeline With Chromatography Innovations

Challenges To Developing High Concentration Formulation For Multi-Specific Antibodies

CaptureSelect Affinity Chromatography

Ensuring Quality, Driving Customer Confidence

Boost Scalability And Efficiency With Automated Filtration

Downstream Purification Symposium Overview

Introducing New Technology To A Multi-Specific Antibody Line

Single-pass Tangential Flow Filtration For Bioprocessing

Intensified Virus Purification: Better, Faster, Virus Production

Strategies For Viral Inactivation And Filtration In Multispecifics

Optimized Purity Of A Monoclonal Antibody, Carsten Voß Video

Targeting The Fast Lane With Optimized Viral Detection

Biopharma Supply, Reimagined: Blarney, A Climate-Neutral Facility For Best-In-Class Filters

What Is Mixed-Mode Chromatography?

Pellicon® Capsule: How Is It Made And How Does It Work?

Purification Strategies For New Classes Of Antibodies

Multi-Specific Antibody Development: What Challenges The Need For Speed?

Maintaining Downstream Quality In Multi-Specific Antibody Manufacturing

The Blazar® Platform In A Minute

Redefine Your Oligonucleotide Manufacturing

Meet The Experts: Part 3 - Chemometrics And Model Building

Challenges To Developing High Concentration Formulation For Multi-Specific Antibodies

Methods To Process Intensification, Downstream Challenges In Continuous Manufacturing

Software To Standardize Pipetting Technique And Assess Operator Competency

Q&A On Continuous Manufacturing In Biopharma

Meet The Experts: Part 4 – Applications And Use Of Raman In Bioprocessing

System To Simplify Single-Channel Pipette Calibration And User Training

Applications For PAT And Continuous: Seed Trains & Data Anomalies

Why PAT Is Foundational To Continuous Manufacturing & What Stands In The Way

Process Intensification: Challenges, Trends, And Industry Takeaways

Process Development With Chromatography Resins And Expert Support

Flexibility First: A Fill And Finish Collaboration Story

Fill And Finish: Your Final Step Is Our First Priority

Simplifying Final Filling - Single-Use Transfer And Filling Solutions

Streamline Production With A Final Filling Single-Use Set

A Contamination-Reducing Solution In Aseptic Transfer

Enhancing Aseptic Fill-Finish Processes

BioTitan Retention Device Overview

Maximize Your Drug Product Recovery With A Complete Fill Finish Solution

Single-Use Filter Transfer Sets Ready For Final Filling

Mycap® Bottle Closures – Aseptic Fluid Transfer Systems For Bottles

Isolator Fill-Finish Process With Single-Use (SU) Systems

MilliporeSigma Large Scale Capabilities Tour

Enabling Assurance Of Supply Through Evolving Bioprocessing Needs

How Will U.S. Tariffs And The BIOSECURE Act Impact Global Biopharma Markets?

Create A Single Source Of Data Truth With Data Management Technology

How Is U.S. Policy Reshaping Global Biomanufacturing Operations?

Virus Risk Mitigation In The Development Of Biological Medicinal Products: A Global Regulatory Perspective Vaccine Cell Bank And Virus Seed Characterization

Protecting Biopharma Manufacturing Supply Chains

Building Resilience In Biomanufacturing Operations

How To Improve API Solubility By Salt And Cocrystal Formation

Biopharma Resilience: CDMOs Secure Supply Chain Management

Singapore Single-Use Site Capacity Expansion

Bioprocessing Raw Material And Equipment Costs Are Slow To Recover Post-Pandemic

Thermo Fisher Scientific Single-Use Global Manufacturing Network

Engineering Bacterial Vector-Based Immunotherapies With OS Therapies' Paul Romness and Robert Petit, Ph.D.

MilliporeSigma Bio-Expo Live February 2025: Upstream Bioprocessing

Closing The Data Package Gap For In-House 3D Printed Parts

Strategies To Reduce Regulatory Risks In Gene Therapy

How Is U.S. Policy Reshaping Global Biomanufacturing Operations?

The ICH Q5A Revision, Its New Scope And Guidance

Legal & Compliance Impact On Speed In The Antibody Market

Master The 2-Point Calibration Process To Maintain Data Integrity

Process Intensification: Challenges, Trends, And Industry Takeaways

Custom GMP-Grade Oligos

Standards' Role In Biosimilarity Assessment

In The U.S., Pharmacy-Level Biosimilar Substitution Remains A High Bar

Structuring CGT Deals for the Long Term with Troutman Pepper Locke's EA Weeks, J.D., Ph.D.

Shaping Drug Development by Starting with the Disease with Roche's Sylke Poehling, Ph.D.

Why Autoimmune CAR T Needs a New Patient-Centered Playbook with Dr. Panteli Theocharous

Reimagining Solid Tumor Immunotherapy Through Engineered Tregs with CoRegen's Dr. Sonal Gupta

Rewriting the Playbook for Stargardt Disease with Atsena Therapeutics' Shannon Boye, Ph.D.

How Precision Oncology Is Redefining Cancer Drug Development with Aprea Therapeutics' Dr. Oren Gilad

Exploring Dendritic Cell Therapy for Solid Tumors with Diakonos Oncology's Jay Hartenbach

Cell & Gene: The Podcast Presents: Better Biopharma's Editors' Roundtable — A Midyear Look at the 2026 Life Sciences Industry

Why In Vivo Therapies Are Moving Toward the Clinic with Ascidian Therapeutics' Dr. Mike Ehlers

Reimagining In Vivo Gene Editing Through Base Editing and Targeted Delivery with Beam Therapeutics' Gopi Shanker, Ph.D.

Advancing CAR T for Drug-Free Remission in Autoimmune Disease with Kyverna Therapeutics' Dr. Naji Gehchan

The Future of In Vivo Gene Editing and Clinical Translation with Precision Biosciences' Cassie Gorsuch, Ph.D.

2026 Regulatory Updates And Operation TrialBlazer

Focusing On Quality Unit Independence With Tatyana Matveeva, Ph.D.

Developing Multi-Targeted T-Cell Engagers With Deck Bio's Johanna Kaufmann

Fixing AAV Recovery With Siren Biotechnology's Nathalie Clément, Ph.D.

Digitalizing The Biopharma Ecosystem With Kat Kozyrytska

Modulating Multispecific Manufacturability With AP Biosciences' JJ You, Ph.D.

The Facility Master Planning Playbook With Herman Bozenhardt

Cell Therapy Without The Cells: Building A Therapeutic Secretome With Noveome Biotherapeutics' Larry Brown, Sc.D.

The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry

Validation Challenges Facing Advanced Single-Use Technologies

Aligning Upstream And Downstream Development (Part 2)

Aligning Upstream And Downstream Development (Part 1)